Medicine  
Indication  
Acamprosate 
Acetylsalicylic acid + atorvastatin + ramipril 
Alcohol use disorder 
Prevention of atherosclerotic cardiovascular diseases 
Acetylsalicylic acid + simvastatin + ramipril 
+ atenolol + hydrochlorothiazide 
Ansuvimab 
Prevention of atherosclerotic cardiovascular diseases 
Atoltivimab + maftivimab + odesivimab 
Ebola virus disease 
Ebola virus disease 
Atorvastatin + perindopril + amlodipine 
Cabergoline  
Prevention of atherosclerotic cardiovascular diseases 
Hyperprolactinaemia 
Ceftolozane + tazobactam 
Cladribine 
Multidrug resistant bacterial infections 
Multiple sclerosis 
Cryoprecipitate, pathogen-reduced 
Deferasirox  
Bleeding disorders 
Iron overload 
Glatiramer acetate 
Letrozole 
Multiple sclerosis 
Infertility 
Levetiracetam  
Naltrexone 
Partial- and generalized-onset seizures, status epilepticus 
Alcohol use disorder 
Octreotide 
Olanzapine 
Gigantism and acromegaly 
Schizophrenia and related psychoses 
Pegfilgrastim 
Pegylated liposomal doxorubicin 
Febrile neutropenia prophylaxis 
Kaposi sarcoma 
Pretomanid 
Quetiapine 
Multidrug-resistant tuberculosis 
Bipolar disorder 
Resin-based composites 
Ravidasvir 
Dental caries 
Hepatitis C virus infection 
Sevoflurane 
Triamcinolone hexacetonide 
General anaesthesia 
Juvenile idiopathic arthritis 
EML - New indications 
Medicine  
Indication  
Cyclophosphamide 
Cytarabine 
Anaplastic large cell lymphoma 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis 
Dexamethasone 
Doxorubicin 
Anaplastic large cell lymphoma 
Anaplastic large cell lymphoma 
Ethionamide 
Etoposide 
Drug-susceptible tuberculosis meningitis 
Anaplastic large cell lymphoma 
Fluoxetine 
Ifosfamide 
Generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive
compulsive disorder 
Anaplastic large cell lymphoma 
Immunoglobulin 
Mercaptopurine 
Langerhans cell histiocytosis 
Langerhans cell histiocytosis 
Methotrexate 
Mifepristone – misoprostol 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis, psoriasis 
Intrauterine fetal demise 
23 
The selection and use of essential medicines 2023 
Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines 
Prednisolone 
Rituximab 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis 
Multiple sclerosis, Burkitt lymphoma 
Vinblastine 
Vincristine 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis 
Langerhans cell histiocytosis 
EML - New formulation/strength 
Medicine  
Formulation/strength  
Arsenic trioxide 
Calcium folinate 
Concentrate for solution for infusion: 2 mg/mL 
Injection: 7.5 mg/mL in 2 mL ampoule; 10 mg/mL in 5 mL ampoule 
Carbamazepine 
Cefotaxime 
Tablet (scored): 400 mg 
Powder for injection: 500 mg; 1 g; 2 g (as sodium) in vial 
Ceftriaxone 
Cytarabine 
Powder for injection: 500 mg (as sodium) in vial 
Injection: 100 mg/mL 
Dacarbazine 
Daunorubicin 
Powder for injection: 200 mg in vial 
Injection: 2 mg /mL; 5 mg/mL in vial 
Powder for injection: 20 mg in vial 
Doxorubicin 
Enalapril 
Injection: 2 mg/mL (hydrochloride) in 5 mL, 25 mL vial 
Tablet: 10 mg (as hydrogen maleate) 
Etoposide 
Ferrous salt + folic acid 
Powder for injection: 100 mg (as phosphate) in vial 
Tablet: equivalent to 60 mg elemental iron + 2.8 mg folic acid 
Fluoride 
Gel: containing 2500 to 12 500 ppm fluoride (any type) 
Mouthrinse: containing 230 to 900 ppm fluoride (any type) 
Varnish: containing 22 500 ppm fluoride (any type) 
Furosemide 
Injection: 10 mg/mL in 5 mL ampoule 
Tablet: 20 mg 
Insulin injection (soluble) 
Intermediate-acting insulin 
Injection: 100 IU/mL in 3 mL cartridge or pre-filled pen. 
Injection: 100 IU/mL in 3 mL cartridge or pre-filled pen. 
Methotrexate 
Injection: 50 mg/2 mL (Section 8.2.1) 
Concentrated injection: 1000 mg/10 mL (Section 8.2.1) 
Nicotine replacement therapy 
Lozenge: 2 mg, 4 mg 
Oral spray: 1 mg per actuation 
p-aminosalicylate sodium 
Pegaspargase 
Powder for oral solution: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) 
Powder for injection: 3,750 units in vial 
Pentamidine 
Valproic acid (sodium valproate) 
Powder for injection: 300 mg (as isethionate) in vial 
Injection: 100 mg/mL in 3 mL ampoule 
EML – Medicines/formulations deleted 
Medicine  
Formulation/strength  
Amikacin 
Chloramphenicol 
Injection: 100 mg/2 mL (as sulfate) in 2 mL vial (Section 6.2.5) 
Capsule 250 mg 
Oral liquid: 150 mg/5 mL (as palmitate) 
Chlorpromazine 
Injection: 25 mg/mL (hydrochloride) in 2 mL ampoule 
Oral liquid: 25 mg/5 mL (hydrochloride)* 
Tablet: 10 mg; 25 mg; 50 mg; 100 mg (hydrochloride)* 
*Oral formulations of chlorpromazine are now included as therapeutic alternatives 
under the square box listing for oral haloperidol (Section 24.1) 
Dasabuvir 
Ethionamide 
Tablet: 250 mg 
Tablet: 125 mg 
24 
The selection and use of essential medicines 2023 
Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines 
Hydroxycarbamide 
Linezolid 
Solid oral dosage form: 250 mg 
Powder for oral liquid: 100 mg/5 mL (Section 6.2.5) 
Tablet: 400 mg (Section 6.2.3) 
Nifurtimox 
Nystatin 
Tablet: 250 mg 
Tablet: 100 000 IU 
Ombitasvir + paritaprevir + ritonavir 
p-aminosalicylic acid 
Tablet: 12.5 mg + 75 mg + 50 mg 
Granules: 4 g in sachet 
Paracetamol 
Pegylated interferon alfa (2a or 2b) 
Tablet: 100 mg 
Vial or pre-filled syringe: 180 micrograms (peginterferon alfa 2a); 80 micrograms, 
100 micrograms (peginterferon alfa 2b) 
Pentamidine 
Phenytoin 
Powder for injection: 200 mg (as isethionate) in vial 
Oral liquid: 25 mg/5 mL (phenytoin) 
Pyrantel 
Oral liquid: 50 mg/mL (as embonate or pamoate)


Table 2: Recommended changes on the 2023 EMLc 
EMLc – New medicines added 
Medicine 
Indication  
Ansuvimab 
Atoltivimab + maftivimab + odesivimab 
Ebola virus disease 
Ebola virus disease 
Ceftolozane + tazobactam 
Cryoprecipitate, pathogen-reduced 
Multidrug resistant bacterial infections 
Bleeding disorders 
Deferasirox  
Levetiracetam  
Iron overload 
Partial- and generalized-onset seizures, status epilepticus 
Pegfilgrastim 
Pegylated liposomal doxorubicin 
Febrile neutropenia prophylaxis 
Kaposi sarcoma 
Ready-to-use therapeutic food 
Resin-based composites 
Severe acute malnutrition 
Dental caries 
Selenium sulfide 
Sevoflurane  
Seborrhoeic dermatitis, pityriasis versicolor 
General anaesthesia 
Triamcinolone hexacetonide 
Juvenile idiopathic arthritis 
EMLc - New indications 
Medicine 
Indication  
Cyclophosphamide 
Cytarabine 
Anaplastic large cell lymphoma 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis 
Dexamethasone 
Doxorubicin 
Anaplastic large cell lymphoma 
Anaplastic large cell lymphoma 
Ethionamide 
Etoposide 
Drug-susceptible tuberculosis meningitis 
Anaplastic large cell lymphoma 
Ifosfamide 
Immunoglobulin 
Anaplastic large cell lymphoma 
Langerhans cell histiocytosis 
Mercaptopurine 
Methotrexate 
Langerhans cell histiocytosis 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis, psoriasis 
Prednisolone 
Rituximab 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis 
Burkitt lymphoma 
Vinblastine 
Vincristine 
Anaplastic large cell lymphoma, Langerhans cell histiocytosis 
Langerhans cell histiocytosis 
EMLc - New formulation/strength 
Medicine 
Formulation/strength  
Adalimumab 
Albendazole 
Injection: 10 mg/0.2 mL; 20 mg/0.4 mL 
Tablet (chewable): 200 mg (Section 6.1.4) 
Amikacin 
Amoxicillin 
Injection: 50 mg/mL (as sulfate) in 2 mL vial (Section 6.2.1) 
Tablet (dispersible, scored): 250 mg; 500 mg (as trihydrate) 
Amoxicillin + clavulanic acid 
Arsenic trioxide 
Tablet (dispersible): 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg 
(as trihydrate) + 62.5 mg (as potassium salt) 
Concentrate for solution for infusion: 2 mg/mL 
Azathioprine 
Oral liquid: 10 mg/mL 
Powder for injection: 50 mg (as sodium salt) in vial 
Tablet: 25 mg 
Azithromycin 
Powder for oral liquid: 200 mg/5 mL (anhydrous) 
26 
The selection and use of essential medicines 2023 
Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines 
Calcium folinate 
Carbamazepine 
Injection: 7.5 mg/mL in 2 mL ampoule; 10 mg/mL in 5 mL ampoule 
Tablet (scored): 400 mg 
Cefalexin 
Cefotaxime 
Tablet (dispersible): 125 mg; 250 mg 
Powder for injection: 500 mg; 1 g; 2 g (as sodium) in vial 
Ceftriaxone 
Ciclosporin 
Powder for injection: 500 mg (as sodium) in vial 
Oral solution: 100 mg/mL 
Ciprofloxacin 
Clarithromycin 
Solid oral dosage form: 100 mg (as hydrochloride) 
Solid oral dosage form: 250 mg 
Clindamycin 
Cloxacillin 
Powder for oral liquid: 75 mg/5 mL (as palmitate hydrochloride) 
Capsule: 250 mg 
Powder for injection: 250 mg (as sodium) in vial 
Powder for oral liquid: 250 mg/5 mL (as sodium) 
Cytarabine 
Dacarbazine 
Injection: 100 mg/mL 
Powder for injection: 200 mg in vial 
Daunorubicin 
Injection: 2 mg /mL; 5 mg/mL in vial 
Powder for injection: 20 mg in vial 
Digoxin 
Injection: 100 micrograms/mL in 1 mL ampoule 
Tablet: 125 micrograms 
Doxorubicin 
Doxycycline 
Injection: 2 mg/mL (hydrochloride) in 5 mL, 25 mL vial 
Powder for oral liquid: 25 mg/5 mL (monohydrate) 
Oral liquid: 50 mg/5 mL (calcium) 
Tablet (dispersible): 100 mg (as monohydrate) 
Enalapril 
Oral solution: 1 mg/mL (as hydrogen maleate) 
Tablet: 10 mg (as hydrogen maleate) 
Etoposide 
Fluconazole 
Powder for injection: 100 mg (as phosphate) in vial 
Powder for oral liquid: 50 mg/5 mL 
Fluoride 
Gel: containing 2500 to 12 500 ppm fluoride (any type) 
Mouthrinse: containing 230 to 900 ppm fluoride (any type) 
Varnish: containing 22 500 ppm fluoride (any type) 
Furosemide 
Injection: 10 mg/mL in 5 mL ampoule 
Oral liquid: 50 mg/5 mL 
Tablet: 20 mg 
Hydroxycarbamide 
Ibuprofen 
Solid oral dosage form: 100 mg 
Oral liquid: 100 mg/5 mL  
Insulin injection (soluble) 
Intermediate-acting insulin 
Injection: 100 IU/mL in 3 mL cartridge or pre-filled pen. 
Injection: 100 IU/mL in 3 mL cartridge or pre-filled pen. 
Linezolid 
Mebendazole 
Tablet (dispersible): 150 mg (Section 6.2.3) 
Tablet (chewable): 100 mg (Section 6.1.4) 
Mercaptopurine 
Methotrexate 
Oral liquid: 20 mg/mL 
Injection: 50 mg/2 mL (Section 8.2.1) 
Concentrated injection: 1000 mg/10 mL (Section 8.2.1) 
Nifurtimox 
Nitrofurantoin 
Tablet (scored): 30 mg (Section 6.5.5.1) 
Solid oral dosage form: 50 mg 
p-aminosalicylate sodium 
Paracetamol 
Powder for oral solution: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) 
Oral liquid: 250 mg/5 mL 
Suppository: 250 mg 
Tablet (dispersible): 100 mg; 250 mg 
27 
The selection and use of essential medicines 2023 
Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines 
Pegaspargase 
Pentamidine 
Powder for injection: 3,750 units in vial 
Powder for injection: 300 mg (as isethionate) in vial 
Phenobarbital 
Praziquantel 
Injection: 30 mg/mL or 60 mg/mL (sodium) 
Tablet: 150 mg (Section 6.1.3 & 6.1.4) 
Tablet: 500 mg (Section 6.1.1 & 6.1.3) 
Rifampicin 
Sulfamethoxazole + trimethoprim 
Oral liquid: 20 mg/mL (Section 6.2.4) 
Tablet (dispersible): 100 mg + 20 mg (Section 6.2.1 and 6.5.4) 
Valproic acid (sodium valproate) 
Vancomycin (IV)  
Injection: 100 mg/mL in 3 mL ampoule 
Powder for injection: 500 mg; 1 g (as hydrochloride) in vial 
EMLc – Medicines/formulations deleted 
Medicine 
Formulation/strength 
Amikacin 
Azithromycin 
Injection: 100 mg/2 mL (as sulfate) in 2 mL vial (Section 6.2.5) 
Oral liquid: 200 mg/5 mL 
Chloramphenicol 
Capsule 250 mg 
Oral liquid: 150 mg/5 mL (as palmitate) 
Chlorpromazine 
Injection: 25 mg/mL (hydrochloride) in 2 mL ampoule 
Oral liquid: 25 mg/5 mL (hydrochloride) 
Tablet: 10 mg; 25 mg; 50 mg; 100 mg (hydrochloride) 
Clarithromycin 
Clindamycin 
Solid oral dosage form: 500 mg 
Oral liquid: 75 mg/5 mL (as palmitate) 
Dasatinib 
Doxycycline 
Tablet: 100 mg; 140 mg 
Oral liquid: 25 mg/5 mL (anhydrous) 
Ethambutol 
Ethionamide 
Oral liquid: 25 mg/mL 
Tablet: 125 mg 
Haloperidol 
Injection: 5 mg in 1 mL ampoule 
Oral liquid: 2 mg/mL 
Solid oral dosage form: 0.5 mg; 2 mg; 5 mg 
Fluoxetine 
Furosemide 
Solid oral dosage form: 20 mg (as hydrochloride) (Section 2.3 & 24.2.1) 
Tablet: 10 mg 
Hydroxycarbamide 
Isoniazid 
Solid oral dosage form: 250 mg 
Oral liquid: 50 mg/5 mL 
Levamisole 
Linezolid 
Tablet: 150 mg (as hydrochloride) 
Powder for oral liquid: 100 mg/5 mL (6.2.5) 
Tablet: 400 mg; 600 mg (6.2.3) 
Nifurtimox 
Nystatin 
Tablet: 250 mg 
Oral liquid: 50 mg/5 mL 
Tablet: 100 000 IU 
p-aminosalicylic acid 
Paracetamol 
Granules: 4 g in sachet 
Tablet: 100 mg 
Pentamidine 
Phenytoin 
Powder for injection: 200 mg (as isethionate) in vial) 
Oral liquid: 25 mg/5 mL (phenytoin) 
Pyrantel 
Pyrazinamide 
Oral liquid: 50 mg/mL (as embonate or pamoate) 
Oral liquid: 30 mg/mL